Get started
Author

Colm B. Farrell

Observed names: C FARRELL, C Farrell, C. B. Farrell, C. Farrell, C.B. Farrell, Colm Farrell
Institution: ICON PLC (Ireland)
Observed institutions: University College Dublin, Icon (United Kingdom), Icon (United States), Alkermes (United States), Imperial Consultants, ICON PLC (Ireland), Trevena, Inc. (United States)
OpenAlex ID: A5111769584
Pharmacokinetic Profile of Ganciclovir After its Oral Administration and From its Prodrug, Valganciclovir, in Solid Organ Transplant Recipients
2005 · Hugh Wiltshire, Sarapee Hirankarn, et al. · Clinical Pharmacokinetics · 129
Cholinergic activation of Cl− secretion in rat colonic epithelia
1995 · Kate E. O'Malley, Colm B. Farrell, et al. · European Journal of Pharmacology · 62
Oliceridine (TRV130), a Novel G Protein–Biased Ligand at the μ‐Opioid Receptor, Demonstrates a Predictable Relationship Between Plasma Concentrations and Pain Relief. I: Development of a Pharmacokinetic/Pharmacodynamic Model
2018 · Michael J. Fossler, Brian M. Sadler, et al. · The Journal of Clinical Pharmacology · 47
Population pharmacokinetics of recombinant human C1 inhibitor in patients with hereditary angioedema
2013 · Colm Farrell, Siobhan Hayes, et al. · British Journal of Clinical Pharmacology · 32
PDF
Population Pharmacokinetics of Extended-Release Injectable Naltrexone (XR-NTX) in Patients With Alcohol Dependence
2007 · Joi L. Dunbar, Ryan Z. Turncliff, et al. · Journal of Studies on Alcohol and Drugs · 23
Population pharmacokinetics of farletuzumab, a humanized monoclonal antibody against folate receptor alpha, in epithelial ovarian cancer
2012 · Colm Farrell, Charles Schweizer, et al. · Cancer Chemotherapy and Pharmacology · 21
PDF
Population pharmacokinetic modeling and simulation of maribavir to support dose selection and regulatory approval in adolescents with posttransplant refractory cytomegalovirus
2023 · Kefeng Sun, Siobhan Hayes, et al. · CPT Pharmacometrics & Systems Pharmacology · 18
PDF
Population pharmacokinetic/pharmacodynamic modelling of eltrombopag in healthy volunteers and subjects with chronic liver disease
2013 · Colm Farrell, Siobhan C. Hayes, et al. · British Journal of Clinical Pharmacology · 16
PDF
Oliceridine, a Novel G Protein–Biased Ligand at the μ‐Opioid Receptor, Demonstrates a Predictable Relationship Between Plasma Concentrations and Pain Relief. II: Simulation of Potential Phase 3 Study Designs Using a Pharmacokinetic/Pharmacodynamic Model
2018 · Michael J. Fossler, Brian M. Sadler, et al. · The Journal of Clinical Pharmacology · 14
Population pharmacokinetic and pharmacodynamic analyses of safinamide in subjects with Parkinson's disease
2016 · Luca Loprete, Chiara Leuratti, et al. · Pharmacology Research & Perspectives · 12
PDF
Population Pharmacokinetic and Pharmacodynamic Modeling and Effects on Platelet Counts of Different Dosages of Eltrombopag in Chinese Patients With Chronic Primary Immune Thrombocytopenia
2015 · Kai Wu, Mita Thapar, et al. · Clinical Therapeutics · 12
Safety, pharmacokinetics, and pharmacodynamics of intravenous ferric carboxymaltose in children with iron deficiency anemia
2023 · Bartosz Korczowski, Colm Farrell, et al. · Pediatric Research · 11
PDF
A population pharmacokinetic meta‐analysis of custirsen, an antisense oligonucleotide, in oncology patients and healthy subjects
2017 · Alena Y. Edwards, Anna Elgart, et al. · British Journal of Clinical Pharmacology · 11
PDF
In Vitro/In Vivo Correlation for Modified Release Injectable Drug Delivery Systems
2005 · David Young, Colm Farrell, et al. · Drugs and the pharmaceutical sciences · 8
Pediatric Population Pharmacokinetic Modeling and Exposure–Response Analysis of Ambrisentan in Pulmonary Arterial Hypertension and Comparison With Adult Data
2022 · Malek Okour, Mita M. Thapar, et al. · The Journal of Clinical Pharmacology · 7
PDF
Modeling and Simulation Support Eltrombopag Dosing in Thrombocytopenic Patients with Chronic HCV Infection
2014 · Jianping Zhang, Mita Thapar, et al. · Pharmaceutical Research · 7
Royal academy of medicine in Ireland section of biological sciences
1992 · J. P. Jamison, R. K. McKinley, et al. · Irish Journal of Medical Science (1971 -) · 6
Population pharmacokinetics of atacicept in systemic lupus erythematosus: An analysis of three clinical trials
2023 · Maria Pitsiu, Özkan Yalkinoglu, et al. · CPT Pharmacometrics & Systems Pharmacology · 5
PDF
Population Pharmacokinetic Analysis of Fluticasone Furoate/Umeclidinium Bromide/Vilanterol in Patients with Chronic Obstructive Pulmonary Disease
2019 · Rashmi Mehta, Colm Farrell, et al. · Clinical Pharmacokinetics · 5
PDF
Population Pharmacokinetics of Telbivudine and Determination of Dose Adjustment for Patients With Renal Impairment
2009 · Xiao‐Jian Zhou, June Ke, et al. · The Journal of Clinical Pharmacology · 5
8406 A Phase 1 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZP-3813, a Novel Small Peptide Growth Hormone Receptor Antagonist, in Healthy Subjects
2024 · S Allas, G Ravel, et al. · Journal of the Endocrine Society · 4
PDF
A phase 1 clinical study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of AZP-3813, a novel, small peptide growth hormone receptor antagonist, in healthy subjects
2024 · Soraya Allas, Guillaume Ravel, et al. · Endocrine Abstracts · 4
Population Pharmacokinetics and Exposure–Response Relationships of Maribavir in Transplant Recipients with Cytomegalovirus Infections
2022 · Ivy Song, Grace Chen, et al. · Transplantation and Cellular Therapy · 4
A Physiologically Based Pharmacokinetic Model to Predict Potential Drug–Drug Interactions and Inform Dosing of Acumapimod, an Oral p38 MAPK Inhibitor
2020 · Alex Agyemang, Colm Farrell, et al. · CPT Pharmacometrics & Systems Pharmacology · 4
PDF
D2 Receptor Antagonists Do Not Modify Guanine Nucleotide‐Sensitive Interactions Between Dopamine and D1 Dopamine Receptors Under In Vitro Conditions
1995 · C. B. Farrell, M. Lawlor, et al. · Journal of Neurochemistry · 4
Works count: 39
Citation count: 483
H-index: 11
I10-index: 13
Year
Topic
Type